5 answers we got from the EpiPen hearing — and 5 things that just became more confusing (MYL)
|09/22/2016||Posted by BusinessMediaguide.Com under General World News||
Heather Bresch, the CEO of Mylan — which makes the EpiPen — was grilled by the House Oversight and Government Reform Committee about the drug’s price on Wednesday.
The price of the device, used in emergencies to treat severe allergic reactions, has increased more than 500% since Mylan acquired it in 2007. A two-pack of the EpiPen now has a list price of $608.
The whole experience was filled with yelling, frustration, and a whole lot of EpiPens and poster board charts.
The members of Congress had a lot of questions for Bresch, who testified alongside Doug Throckmorton, a deputy director of read more >>>